268 related articles for article (PubMed ID: 21565138)
1. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on treatment of advanced non-small cell lung cancer with kangliu zengxiao decoction].
Wu J; Xu ZY; Wang ZQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):137-40. PubMed ID: 20462038
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy].
Xu ZY; Jin CJ; Shen DY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Oct; 27(10):874-8. PubMed ID: 17990450
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.
Xu ZY; Jin CJ; Zhou CC; Wang ZQ; Zhou WD; Deng HB; Zhang M; Su W; Cai XY
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1117-22. PubMed ID: 21298288
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Aidi Injection () on overexpression of P-glycoprotein induced by vinorelbine and cisplatin regimen in patients with non-small cell lung cancer.
Ma JJ; Liu HP
Chin J Integr Med; 2017 Jul; 23(7):504-509. PubMed ID: 27484766
[TBL] [Abstract][Full Text] [Related]
6. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
Zhao T; Mao G; Chen M
Comput Math Methods Med; 2021; 2021():1951364. PubMed ID: 34603482
[TBL] [Abstract][Full Text] [Related]
7. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
Dal Bello MG; Filiberti RA; Alama A; Orengo AM; Mussap M; Coco S; Vanni I; Boccardo S; Rijavec E; Genova C; Biello F; Barletta G; Rossi G; Tagliamento M; Maggioni C; Grossi F
J Transl Med; 2019 Mar; 17(1):74. PubMed ID: 30849967
[TBL] [Abstract][Full Text] [Related]
8. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
9. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
Li L; Song LH; Ding SC; Zhang XJ; Qiang L; Han CY; Yuan XT; Xu DD
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):850-4. PubMed ID: 21223692
[TBL] [Abstract][Full Text] [Related]
11. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
Fan CX; Lin CL; Liang L; Zhao YY; Liu J; Cui J; Yang QM; Wang YL; Zhang AR
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):294-7. PubMed ID: 20510083
[TBL] [Abstract][Full Text] [Related]
12. [Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage IIIB/IV non-small-cell lung cancer: a randomized controlled trial].
Deng SQ; Ouyang XN; Yu ZY; Dai XH; Chen X; Fang FZ; Wang WW; Liu ZZ
Zhong Xi Yi Jie He Xue Bao; 2012 Jun; 10(6):635-40. PubMed ID: 22704411
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
14. A randomized controlled pilot trial of "Feiji Recipe" on quality of life of non-small cell lung cancer patients.
Tian JH; Liu LS; Shi ZM; Zhou ZY; Wang L
Am J Chin Med; 2010; 38(1):15-25. PubMed ID: 20128041
[TBL] [Abstract][Full Text] [Related]
15. [Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].
Zhang ZY; Yu SQ; Miao LY; Huang XY; Zhang XP; Zhu YP; Xia XH; Li DQ
Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):134-8. PubMed ID: 18241646
[TBL] [Abstract][Full Text] [Related]
16. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and adverse effets of nimotuzumab plus palitaxel liposome and carboplatin in the treatment for advanced non-small cell lung cancer].
Qi DL; Wang HQ; Li Y; Huang CB; Wang QS; Xu L; Yang YZ; Cui Y; Xin L
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):152-5. PubMed ID: 22780937
[TBL] [Abstract][Full Text] [Related]
18. [Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].
Gu AQ; Han BH; Zhang XY; Shen J; Qi DJ; Xiong LW; Xin Y; Song YY
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):298-301. PubMed ID: 19615288
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Radical Resected NSCLC by Chinese Medicine Combined with Adjuvant Chemother- apy: a Clinical Study].
Hou WX; Li HG; Chen ZW; Zhu LH; Zhao LH; Tian JH; Xu WJ; Zhou L; Yao YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jun; 35(6):648-53. PubMed ID: 26242112
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials.
Xiao Z; Jiang Y; Wang CQ; Hu SS; Huang XR; Chen XF; Huang J; Shan LJ; Tang YH; Wang YH; Gong QH; Feng JH; Xiao X; Li XF
Pharmacol Res; 2020 Mar; 153():104637. PubMed ID: 31935454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
